Your browser doesn't support javascript.
loading
Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.
Yang, Wenying; Xu, Xiangjin; Lei, Tao; Ma, Jianhua; Li, Ling; Shen, Jie; Ye, Binqi; Zhu, Sandy; Meinicke, Thomas.
Afiliación
  • Yang W; China-Japan Friendship Hospital, Beijing, People's Republic of China.
  • Xu X; The 900th Hospital of Joint Logistic Support Force, PLA, Fujian, People's Republic of China.
  • Lei T; Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Ma J; Nanjing First Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
  • Li L; Shengjing Hospital of China Medical University Endocrinology, Liaoning, People's Republic of China.
  • Shen J; Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People's Republic of China.
  • Ye B; Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People's Republic of China.
  • Zhu S; Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People's Republic of China.
  • Meinicke T; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Diabetes Obes Metab ; 23(2): 642-647, 2021 02.
Article en En | MEDLINE | ID: mdl-33074590
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Linagliptina Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Linagliptina Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article